GUTPLUS
LIVE

Serial Number

79194796

Owner

Evonik Operations GmbH

Attorney

Scott D. Woldow

Filing Date

Mar 31, 2016

Add to watchlist:

No watchlists yet
View on USPTO

GUTPLUS Trademark

Serial Number: 79194796 • Registration: 5337457

GUTPLUS is a trademark filed by Evonik Operations GmbH on March 31, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

Evonik Operations GmbH (3 trademarks)

Rellinghauser Str. 1-11

Entity Type: 16

Evonik Degussa GmbH

Rellinghauser Straße 1-11

Entity Type: 16

Trademark Details

Filing Date

March 31, 2016

Registration Date

November 21, 2017

Published for Opposition

September 5, 2017

Cancellation Date

July 14, 2025

Goods & Services

Pharmaceutical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies and disorders; Pharmaceutical and veterinary preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical and veterinary preparations for the prevention and treatment of necrotic enteritis; medical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies and disorders; medical and veterinary preparations for the prevention and for the treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; medical and veterinary preparations, namely, fodder acidifiers for medical purposes and fodder additives for medical purposes in form of amino acids, peptides and proteins and mixtures thereof; medical and veterinary preparations for the prevention and for the treatment of necrotic enteritis; chemical preparations for medical, pharmaceutical and veterinary purposes for the prevention and for the treatment of nutrition deficiencies and disorders; chemical preparations for medical, pharmaceutical and veterinary purposes for the prevention and for the treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; chemical preparations for medical, pharmaceutical and veterinary purposes for the prevention and for the treatment of necrotic enteritis; amino acids for medical and veterinary purposes; esters, oils and greases for medical and veterinary purposes; salts, in particular potassium and sodium salts for medical purposes; steroids; ferments for pharmaceutical purposes; yeast or starch for dietetic or pharmaceutical purposes; enzymes and enzyme preparations for medical and veterinary purposes; biological preparations for the treatment of nutrition conditions; bacteriological preparations for medical and veterinary purposes; cultures of microorganisms for medical and veterinary use; nutritive substances for microorganisms for medical purposes; bouillons for bacteriological cultures; dietetic foods, namely pasta and crackers adapted for medical or veterinary use; dietetic preparations, namely sugar substitutes for medical use and dietary supplements; albuminous preparations for medical purposes; candy, medicated; medicinal drinks; dietetic beverages adapted for medical purposes; medical preparations for slimming purposes; food for babies; nutritional supplements for humans; dietary supplements for animals; Medical preparations, namely, probiotic supplements; Dietary supplements for animals, namely, probiotic animal feed; nutritional supplements for humans, namely, probiotic compositions; sugar, in particular candy and glucose for medical purposes; glucose for medical purposes; albuminous foodstuffs for medical purposes; protein dietary supplements; dietary fibre; mineral food supplements; preparations of trace elements for human and animal use; vitamin preparations; animal feed supplements, not for medical purposes; animal feed supplements, namely, non-medicated additives for animal feed for use as nutritional supplements; micro-nutrient animal feed for fish and aquacultures; feed supplements, namely synthetic peptides for the treatment of nutrition deficiencies; protein supplements for animals; amino acids for nutritional purposes for use in animal feed, fish food and aquaculture

Agricultural, horticultural and forestry products as well as products for aquaculture, namely, aquaculture feed; live animals; foodstuffs and fodder for animals; bedding and litter for animals, namely, cellulose for use as animal bedding; animal feed preparations, namely, animal feed; yeast for animal consumption

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 14, 2026 INTR
NOTICE OF CANCELLATION SEC. 71 E-MAILED
Jul 14, 2025 NC71
CANCELLED SECTION 71
Jul 14, 2025 C71T
POST REGISTRATION ACTION MAILED - SEC.71
Dec 17, 2024 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 16, 2024 APRE
TEAS SECTION 71 RECEIVED
May 17, 2024 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 21, 2022 REM3
CHANGE OF OWNER RECEIVED FROM IB
May 14, 2020 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 13, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 22, 2018 FICS
FINAL DISPOSITION PROCESSED
Feb 22, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 21, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 21, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2017 NPUB
PUBLISHED FOR OPPOSITION
Sep 5, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 17, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 11, 2017 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 6, 2017 GNFN
FINAL REFUSAL E-MAILED
Jun 6, 2017 GNFR
FINAL REFUSAL WRITTEN
Jun 6, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2017 CRFA
ASSIGNED TO LIE
May 24, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2017 TROA
REFUSAL PROCESSED BY IB
Nov 18, 2016 RFNT
APPLICATION FILING RECEIPT MAILED
Nov 5, 2016 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 3, 2016 RFCS
REFUSAL PROCESSED BY MPU
Nov 3, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 2, 2016 RFCR
NON-FINAL ACTION WRITTEN
Nov 1, 2016 CNRT
ASSIGNED TO EXAMINER
Nov 1, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 27, 2016 REPR